anti-Her-2/anti-Ang2 mAb (Zyngenia)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-Her-2/anti-Ang2 mAb (Zyngenia)

Drug Alias NameHer-Ang2

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAngiopoietin-2 inhibitorsReceptor protein-tyrosine kinase erbB-2 antagonistsEpidermal growth factor receptor erbB1 antagonists +[5]

TargetsInsulin-like growth factor I receptorAngiopoietin-2Epidermal growth factor receptor erbB1 +[5]

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesZyngenia Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesZyngenia Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A